Zoonotic & Vector-Borne Diseases

Researchers may have discovered a way to prevent Zika, Dengue and Chikungunya viruses from replicating in human cells.

Jean-Paul Gonzalez, MD, PhD, Deputy Director, Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Kansas State University, Adjunct Professor, Kansas State University, discusses the parallels between past Ebola outbreaks, and how they can help us manage the current Zika pandemic.

The NIH has developed a platform called SHERLOCK, capable of quickly detecting small amounts of nucleic acid sequences—and it’s cheap.

In case you missed them, here are our top 5 articles for the week of April 23, 2017.

Manufacturing issues have led to a shortage of the only yellow fever vaccine licensed in the United States; now, that shortage is expected to lead to a complete depletion of available vaccine by mid-2017.

Two studies published in the Centers for Disease Control and Prevention's Emerging Infectious Diseases journal have outlined just how local and travel-related Zika cases differ, as well as which testing method is most sensitive to Zika virus RNA.

The New England Journal of Medicine recently published two pieces on yellow fever. The first reports on the situation in the Americas, while the second recounts the case of a man from Angola who was found to be coinfected with yellow fever and Japanese encephalitis virus, although he reported no history of travel.

On World Malaria Day, the world focuses on how to eliminate malaria once and for all.

Adriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.

In case you missed them, here are our top 5 articles for the week of April 16, 2017.

A new report from Centers for Disease Control and Prevention reveals information on a 5-month-old male infant who was diagnosed with the emerging tick-borne virus in Connecticut in 2016.

Researchers report that Zika virus RNA was isolated in a number of Aedes albopictus mosquitoes in Bahia, Brazil.

Researchers from The University of Texas Medical Branch at Galveston (UTMB) and Instituto Evandro Chagas (IEC) have published their findings on the live-attenuated vaccine candidate in the journal Nature Medicine.

David A. Schwartz, MD, MS Hyg, FCAP, clinical professor of pathology at Medical College of Georgia, Augusta University, explains his research, which focuses on mechanisms of transmission of the Zika virus from mother to child.

Hawaii is experiencing a cluster of rat lungworm disease cases on the Big Island as well as on the island of Maui; a few suspected cases are still undergoing investigation.

The Texas Department of State Health and Human Services has changed its testing recommendations for residents in six counties.

In case you missed them, here are our top 5 articles for the week of April 2, 2017.

Alice Panchaud, PharmD, PhD, clinical pharmacist and pharmacoepidemiologist, CHUV, Lausanne University Hospital, Switzerland, explains how researchers can anonymously enter patient data to the international Zika virus registry, which collects data on women exposed to the mosquito-borne virus during pregnancy.

Robert Bransfield, MD, DLFAPA, Associate Clinical Professor, Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, examines the clinical and laboratory definitions of Lyme disease.

News on Heliobacter pylori, Zika, Clostridium difficile, Powassan virus, and influenza make up the top 5 news articles from Contagion® in March 2017.

The Centers for Disease Control and Prevention (CDC) recently reported that they are seeing between 30 to 40 new cases of Zika virus in pregnant women in the United States each week.

Robert Bransfield, MD, DLFAPA, Associate Clinical Professor, Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, discusses the existence of chronic Lyme disease.

Health officials in Florida declare that they are better prepared for a potential outbreak in their state as Zika vaccinations have begun in a multi-site Phase II/IIb clinical trial of VRC705 in areas of endemic Zika transmission throughout the world.

Carmen Zorrilla, MD, professor of obstetrics and gynecology, University of Puerto Rico, School of Medicine, discusses how the model of prenatal care centering works.

Researchers recently examined whether or not some virus families are better able to jump across species boundaries and emerge in new hosts than others.